4.7 Article

Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis

Nayara Felicidade Tomaz Braz et al.

Summary: The study compared serum levels of RAS components in women with RA and healthy females, finding differences and associations with subclinical atherosclerosis. The imbalance of RAS axes may be related to cardiovascular risk and disease activity in rheumatoid arthritis patients. Ultrasonography of carotid arteries can help identify early atherosclerotic disease in RA patients.

MODERN RHEUMATOLOGY (2021)

Review Rheumatology

Cardiovascular effects of approved drugs for rheumatoid arthritis

Fabiola Atzeni et al.

Summary: Various drugs used in the management of rheumatoid arthritis have anti-inflammatory effects that can hinder atherosclerosis development, but they may also increase cardiovascular risk. While controlling inflammation can reduce the progression of atherosclerosis, some drugs may also directly or indirectly promote atherosclerosis. The primary objective for clinicians should be disease control, selecting the most appropriate drug for each patient while considering joint and cardiovascular outcomes.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Peripheral Vascular Disease

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Thomas Unger et al.

HYPERTENSION (2020)

Article Biochemistry & Molecular Biology

Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis

Takahiko Akagi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Rheumatology

Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure

Joshua F. Baker et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2018)

Review Medicine, General & Internal

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

Bryant R. England et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Medicine, General & Internal

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

Bryant R. England et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Cardiac & Cardiovascular Systems

Rheumatoid arthritis and risk of cardiovascular disease

Pieter W. A. Meyer et al.

CARDIOVASCULAR JOURNAL OF AFRICA (2018)

Article Rheumatology

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Cynthia S. Crowson et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

Article Rheumatology

Cardiovascular disease in inflammatory rheumatic diseases

Santos Castaneda et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2016)

Review Immunology

Angiotensin II in inflammation, immunity and rheumatoid arthritis

Y. Chang et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)

Article Pharmacology & Pharmacy

Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats

Mariam Gamal Fahmy Wahba et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Article Rheumatology

Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis

Anne M. Kerola et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

Article Public, Environmental & Occupational Health

Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

Hilda J. I. de Jong et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)

Review Pharmacology & Pharmacy

Protective effects of angiotensin II interruption: Evidence for antiinflammatory actions

NJ Dagenais et al.

PHARMACOTHERAPY (2005)

Review Pharmacology & Pharmacy

Angiotensin II-receptor blockers: Clinical relevance and therapeutic role

JE Rodgers et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2001)